Carvolix (XPAR:CVX) EBIT per Share: €-0.44 (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:CVX Carvolix SA XPAR:CVX
30 GF Score
Price €6.04
! 1 Warning Sign
View Full Analysis

What is Carvolix EBIT per Share?

Carvolix XPAR:CVX +7.86% 30 EBIT per Share is €-0.44 as of Jun. 2025. GuruFocus rates XPAR:CVX with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 686 Medical Devices & Instruments companies, Carvolix ranks better than 64.43% on this metric.

Carvolix's EBIT per Share for the six months ended in Jun. 2025 was €-0.23. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2025 was €-0.44.

During the past 3 years, the average EBIT per Share Growth Rate was 19.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 18.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Carvolix's EBIT per Share or its related term are showing as below:

XPAR:CVX' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -25   Med: 12.7   Max: 20
Current: 19.6

During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Carvolix was 20.00% per year. The lowest was -25.00% per year. And the median was 12.70% per year.

XPAR:CVX's 3-Year EBIT Growth Rate is ranked better than
64.43% of 686 companies
in the Medical Devices & Instruments industry
Industry Median: 9.25 vs XPAR:CVX: 19.60

Carvolix's EBIT for the six months ended in Jun. 2025 was €-9.09 Mil.

Carvolix  (XPAR:CVX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Carvolix EBIT per Share Related Terms

Carvolix EBIT per Share Historical Data

* Premium members only.

The historical data trend for Carvolix's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carvolix EBIT per Share Chart

Carvolix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.72 -0.78 -0.53 -0.40 -0.43

Carvolix Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.26 -0.27 -0.15 -0.23 -0.21
XPAR:CVX
30GF Score
Carvolix SA XPAR:CVX
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carvolix EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Carvolix's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

EBIT per Share(A: Dec. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-14.365/35.897
=-0.40

Carvolix's EBIT per Share for the quarter that ended in Jun. 2025 is calculated as

EBIT per Share(Q: Jun. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-9.091/39.348
=-0.23

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of €-0.44 mean?
Carvolix (XPAR:CVX) has a EBIT per Share of €-0.44 as of Jun. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Carvolix and its competitors. According to the industry distribution chart, Carvolix ranks #244 out of 686 companies in the Medical Devices & Instruments industry, placing it in the top 35.6%.
Is Carvolix's EBIT per Share too high?
Carvolix's current EBIT per Share is €-0.44. Based on the distribution chart, Carvolix ranks #244 out of 686 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Carvolix has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Carvolix's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Carvolix ranks #244 out of 686 companies for EBIT per Share. This puts Carvolix in the upper half of its industry. The industry median EBIT per Share is 9.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.25, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Carvolix and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carvolix's current EBIT per Share is €-0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carvolix stock overvalued right now?
Carvolix (XPAR:CVX) has a current EBIT per Share of €-0.44. The current EBIT per Share is €-0.44. Carvolix's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Carvolix (XPAR:CVX), the current EBIT per Share is €-0.44 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carvolix Business Description

Other Exchanges 0JZ:Germany
Address 320 Avenue Archimede, Les Pleiades III - Batiment B, Aix-en-Provence, FRA, 13100
Carvolix SA specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
30GF Score

Get the complete analysis for XPAR:CVX

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.04
Price